Dow Down 0.71% Nasdaq Down 1.04%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
89.67 Up 0.88(0.99%) 1:08PM EST - Nasdaq Real Time Price
Prev Close:88.79
Open:87.61
Bid:89.92 x 200
Ask:90.25 x 100
1y Target Est:122.50
Beta:0.908519
Next Earnings Date:10-Feb-16LGND Earnings announcement
Day's Range:86.89 - 93.71
52wk Range:53.53 - 114.00
Volume:306,204
Avg Vol (3m):387,794
Market Cap:1.79B
P/E (ttm):7.38
EPS (ttm):12.15
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LGND

Comparison

Symbol% ChgMkt Cap
LGNDUp 0.99%1.79B
MRKUp 0.04%136.46B
LLYDown 1.52%77.37B

Key Statistics

Forward P/E (1 yr):26.37
P/S (ttm):24.00
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-15) :3.36
Quarterly EPS Est (Dec-15) :0.65
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):0.63

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated operates as a biotechnology company in the United States. The company’s commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis that is used for ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback